Calcitonin Gene-Related Peptide (CGRP) Antagonists and Their Use in Migraines

被引：7
|
作者：
Henson, Brianna [1 ]
Hollingsworth, Hanna [2 ]
Nevois, Erika [3 ]
Herndon, Chris [4 ]
机构：
[1] Wake Forest Baptist Hlth Brenner Childrens Hosp, Winston Salem, NC USA
[2] Parkland Hlth & Hosp Syst, Dallas, TX USA
[3] CVS Pharm, Springfield, IL USA
[4] Southern Illinois Univ Edwardsville, Sch Pharm, 200 Univ Pk Dr, Edwardsville, IL 62026 USA
来源：
JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY | 2020年 / 34卷 / 01期
关键词：
CGRP; migraine; calcitonin gene-related peptide; erenumab; galcanezumab; fremanezumab; DOUBLE-BLIND; EPISODIC MIGRAINE; RECEPTOR ANTAGONISTS; PREVENTIVE TREATMENT; EFFICACY; SAFETY; ANTIBODY; PHASE-2; TRIAL;
D O I：
10.1080/15360288.2019.1690616
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
Migraine is highly prevalent and associated with a large socio-economic burden in the United States. Current preventive medications have variable efficacy and their use is often limited by intolerable side effects. Calcitonin gene-related peptide (CGRP) has been identified as an integral part of migraine pathophysiology. There are currently seven CGRP antagonists under investigation, all of which are undergoing or have completed phase 3 clinical trials. Three of the investigated CGRP antagonists are approved for use within and outside of the United States. The trials have resulted in positive efficacy and safety data. The purpose of this review is to evaluate the seven CGRP antagonists and their future place in therapy.
引用
收藏
页码：22 / 31
页数：10
相关论文
共 50 条
  • [21] Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale
    Cohen, Fred
    Yuan, Hsiangkuo
    Silberstein, Stephen D.
    BIODRUGS, 2022, 36 (03) : 341 - 358
  • [22] RETRACTED: Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information (Retracted Article)
    Omaer, Abubker
    Aldosari, Fahad M.
    McGlamery, Emily
    Wool, Steven
    Fazel, Maryam T.
    Alrashed, Saad
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (01) : I - XVIII
  • [23] Calcitonin gene-related peptide (CGRP) receptor antagonists: Novel aspartates and succinates
    Luo, Guanglin
    Chen, Ling
    Pin, Sokhom S.
    Xu, Cen
    Conway, Charles M.
    Macor, John E.
    Dubowchik, Gene M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (08) : 2912 - 2916
  • [24] Role of Monoclonal Antibodies against Calcitonin Gene-Related Peptide (CGRP) in Episodic Migraine Prevention: Where Do We Stand Today?
    Nagaraj, Karthik
    Vandenbussche, Nicolas
    Goadsby, Peter J.
    NEUROLOGY INDIA, 2021, 69 : S59 - S66
  • [25] Calcitonin gene-related peptide: a key player neuropeptide in migraine
    Ramos-Romero, Marta L.
    Sobrino-Mejia, Fidel E.
    REVISTA DE NEUROLOGIA, 2016, 63 (10) : 460 - 468
  • [26] Calcitonin gene-related peptide antagonist therapy and migraines
    Zolp, Andrew
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (05): : 19 - 20
  • [27] Novel oxazolidinone calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraine
    Crowley, Brendan M.
    Stump, Craig A.
    Nguyen, Diem N.
    Potteiger, Craig M.
    McWherter, Melody A.
    Paone, Daniel V.
    Quigley, Amy G.
    Bruno, Joseph G.
    Cui, Dan
    Culberson, J. Christopher
    Danziger, Andrew
    Fandozzi, Christine
    Gauvreau, Danny
    Kemmerer, Amanda L.
    Menzel, Karsten
    Moore, Eric L.
    Mosser, Scott D.
    Reddy, Vijay
    White, Rebecca B.
    Salvatore, Christopher A.
    Kane, Stefanie A.
    Bell, Ian M.
    Selnick, Harold G.
    Fraley, Mark E.
    Burgey, Christopher S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (21) : 4777 - 4781
  • [28] Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies
    Mehta, Purav
    Ngo, Dat
    Tinajero, Jose
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (07) : 1255 - 1258
  • [29] Orally bioavailable imidazoazepanes as calcitonin gene-related peptide (CGRP) receptor antagonists: Discovery of MK-2918
    Paone, Daniel V.
    Nguyen, Diem N.
    Shaw, Anthony W.
    Burgey, Christopher S.
    Potteiger, Craig M.
    Deng, James Z.
    Mosser, Scott D.
    Salvatore, Christopher A.
    Yu, Sean
    Roller, Shane
    Kane, Stefanie A.
    Selnick, Harold G.
    Vacca, Joseph P.
    Williams, Theresa M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (09) : 2683 - 2686
  • [30] Carbamates as potent calcitonin gene-related peptide antagonists with improved solution stability
    Degnan, Andrew P.
    Conway, Charles M.
    Dalterio, Richard A.
    Macci, Robert
    Mercer, Stephen E.
    Schartman, Richard
    Xu, Cen
    Dubowchik, Gene M.
    Macor, John E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) : 3555 - 3558
12345